Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 78326 - 78350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tetrathiomolybdate	Investigational	SOD2	6648	upregulated	tetrathiomolybdate analog results in increased expression of SOD2 mRNA	6q25.3	A24415
Tetrathiomolybdate	Investigational	SP1	6667	upregulated	tetrathiomolybdate results in increased expression of SP1 mRNA	12q13.13	A22263
Tetrathiomolybdate	Investigational	TXNRD1	7296	upregulated	tetrathiomolybdate analog results in increased expression of TXNRD1 mRNA	12q23.3	A24415
Fedratinib	Approved Investigational	BCL2L1	598	upregulated	TG101348 results in increased expression of BCL2L1 mRNA	20q11.21	A23049
Fedratinib	Approved Investigational	CCND1	595	downregulated	TG101348 results in decreased expression of CCND1 mRNA	11q13.3	A23049
Fedratinib	Approved Investigational	MYC	4609	downregulated	TG101348 results in decreased expression of MYC mRNA	8q24.21	A23049
Fedratinib	Approved Investigational	VEGFA	7422	upregulated	TG101348 results in increased expression of VEGFA mRNA	6p21.1	A23049
Thalidomide	Approved Investigational Withdrawn	ABCB1	5243	downregulated	Thalidomide results in decreased expression of ABCB1 mRNA	7q21.12	A24416
Thalidomide	Approved Investigational Withdrawn	ANXA2	302	downregulated	Thalidomide results in decreased expression of ANXA2 mRNA	15q22.2	A24417
Thalidomide	Approved Investigational Withdrawn	ATF3	467	upregulated	Thalidomide analog results in increased expression of ATF3 mRNA	1q32.3	A24418
Thalidomide	Approved Investigational Withdrawn	CALB1	793	downregulated	Thalidomide results in decreased expression of CALB1 mRNA	8q21.3	A23258
Thalidomide	Approved Investigational Withdrawn	CCL2	6347	downregulated	Thalidomide analog results in decreased expression of CCL2 mRNA	17q12	A24418
Thalidomide	Approved Investigational Withdrawn	CCND1	595	downregulated	Thalidomide analog results in decreased expression of CCND1 mRNA	11q13.3	A24418
Thalidomide	Approved Investigational Withdrawn	CREBRF	153222	upregulated	Thalidomide analog results in increased expression of CREBRF mRNA	5q35.1	A24418
Thalidomide	Approved Investigational Withdrawn	CYP2B6	1555	upregulated	Thalidomide results in increased expression of CYP2B6 mRNA	19q13.2	A24419
Thalidomide	Approved Investigational Withdrawn	CYP3A4	1576	upregulated	Thalidomide results in increased expression of CYP3A4 mRNA	7q22.1	A24419
Thalidomide	Approved Investigational Withdrawn	DDIT3	1649	upregulated	Thalidomide analog results in increased expression of DDIT3 mRNA	12q13.3	A24418
Thalidomide	Approved Investigational Withdrawn	DNAJB1	3337	upregulated	Thalidomide analog results in increased expression of DNAJB1 mRNA	19p13.12	A24418
Thalidomide	Approved Investigational Withdrawn	DNAJB4	11080	upregulated	Thalidomide analog results in increased expression of DNAJB4 mRNA	1p31.1	A24418
Thalidomide	Approved Investigational Withdrawn	DNAJB9	4189	upregulated	Thalidomide analog results in increased expression of DNAJB9 mRNA	7q31.1	A24418
Thalidomide	Approved Investigational Withdrawn	DUSP1	1843	upregulated	Thalidomide analog results in increased expression of DUSP1 mRNA	5q35.1	A24418
Thalidomide	Approved Investigational Withdrawn	DUSP10	11221	upregulated	Thalidomide analog results in increased expression of DUSP10 mRNA	1q41	A24418
Thalidomide	Approved Investigational Withdrawn	DUSP8	1850	upregulated	Thalidomide analog results in increased expression of DUSP8 mRNA	11p15.5	A24418
Thalidomide	Approved Investigational Withdrawn	F2R	2149	downregulated	Thalidomide results in decreased expression of F2R mRNA	5q13.3	A23116
Thalidomide	Approved Investigational Withdrawn	FOS	2353	upregulated	Thalidomide analog results in increased expression of FOS mRNA	14q24.3	A24418

Displaying entries 78326 - 78350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability